London, UK (PRWEB) February 20, 2015
At present, there are no types of pharmacological treatments that are available for celiac disease. With a gluten-free diet being the only treatment, immunosuppressant drugs and steroids can be taken in order to reduce symptoms in severe cases. The latter ones target not more than 5 percent of the celiac disease population, while preventive medications are not available.
However, the anticipated launch of two new drugs over the next few years in the US and 5EU are set to change the landscape and drive growth of the market. Currently, there is no standardized clinical trial design for the disease and trial designs for early stage pipeline drugs are likely to depend on their mechanisms of action (MOA).
Insightful market research study “OpportunityAnalyzer: Celiac Disease - Opportunity Analysis and Forecast to 2023” worked out by GlobalData is available at MarketPublishers.com.
Title: OpportunityAnalyzer: Celiac Disease - Opportunity Analysis and Forecast to 2023
Published: November, 2014
Price: US$ 7,995.00
This in-demand research report offers a detailed discussion of opportunities existing in the celiac disease marketplace. The study covers the disease background; contains details on risk factors as well as comorbidities. Global trends related to the disease and its treatment care discussed in the report too. An epidemiological forecast for the disease through 2023, current treatment options and product profiles are also on hand in the research study. Valuable information on research on development strategies; assessment of the pipeline and pipeline valuation analysis can be found in the report as well.
- in-depth overview of the disease;
- details on therapeutics market revenue (annualized), coverage of annual cost of therapies and future forecasts (for 5 and 10 years);
- strategic product assessment;
- characterization of the market;
- data on unmet needs and R&D strategies;
- examination of pipeline;
- an insight into current and future competition in the US and top 5 EU markets;
- and more.
Other cutting-edge research reports by the publisher can be found at GlobalData page.